BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32446973)

  • 1. Gaps in Opioid Prescription for Severe Breathlessness in Hospitalized Patients With Chronic Obstructive Pulmonary Disease or Interstitial Lung Disease.
    Chen X; Treanor D; Le B; Smallwood N
    J Pain Symptom Manage; 2020 Sep; 60(3):e36-e39. PubMed ID: 32446973
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid Prescription Method for Breathlessness Due to Non-Cancer Chronic Respiratory Diseases: A Systematic Review.
    Yamaguchi Y; Saif-Ur-Rahman KM; Nomura M; Ohta H; Hirakawa Y; Yamanaka T; Hirahara S; Miura H
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic breathlessness in advanced cardiorespiratory disease: patient perceptions of opioid use.
    Moran T; Zentner D; Wong J; Philip J; Smallwood N
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e334-e343. PubMed ID: 33837113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial.
    Ahmadi Z; Sandberg J; Shannon-Honson A; Vandersman Z; Currow DC; Ekström M
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30002106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Vozoris NT
    Am J Respir Crit Care Med; 2021 Jan; 203(2):266-267. PubMed ID: 33022187
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Mammen MJ; Charbek E; Alexander PE; Nici L; Aaron SD
    Am J Respir Crit Care Med; 2021 Jan; 203(2):267-269. PubMed ID: 33022179
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological management of breathlessness in COPD: recent advances and hopes for the future.
    O'Donnell DE; Webb KA; Harle I; Neder JA
    Expert Rev Respir Med; 2016 Jul; 10(7):823-34. PubMed ID: 27115291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
    Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
    Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
    Smallwood N; Le B; Currow D; Irving L; Philip J
    Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease?
    Horton R; Rocker G; Currow D
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):92-6. PubMed ID: 20443250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and management of chronic breathlessness in COPD in a tertiary care center.
    Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F;
    BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.
    Varkey B
    Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes of patients with chronic breathlessness towards treatment with opioids.
    Verberkt CA; van den Beuken-van Everdingen MHJ; Wouters EFM; Janssen DJA
    Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31699842
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease: thinking outside the opioid box.
    Liao S; Arnold RM
    J Palliat Med; 2007 Jun; 10(3):781-2. PubMed ID: 17592990
    [No Abstract]   [Full Text] [Related]  

  • 15. Managing dyspnea in advanced chronic obstructive pulmonary disease: balancing all the evidence.
    Mularski RA; Rocker G
    Ann Am Thorac Soc; 2015 Jul; 12(7):978-80. PubMed ID: 26203609
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Opioids in Patients With Chronic Obstructive Pulmonary Disease and Chronic Breathlessness.
    Widera EW
    JAMA Intern Med; 2020 Oct; 180(10):1315-1316. PubMed ID: 32804196
    [No Abstract]   [Full Text] [Related]  

  • 17. Nebulized morphine for the relief of dyspnea.
    Mabe SR; Connelly JF
    Am J Health Syst Pharm; 1995 Jan; 52(2):146-8. PubMed ID: 12879541
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.
    Ekström M; Nilsson F; Abernethy AA; Currow DC
    Ann Am Thorac Soc; 2015 Jul; 12(7):1079-92. PubMed ID: 25803110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Opioids for refractory dyspnoea in palliation].
    Aabom B; Bendstrup E; Sjøgren P; Løkke A; Shaker B; Wilcke T; Jespersen BA; Hilberg O; Marsaa K
    Ugeskr Laeger; 2020 Sep; 182(40):. PubMed ID: 33000737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid utility for dyspnea in chronic obstructive pulmonary disease: a complicated and controversial story.
    Vozoris NT
    Ann Palliat Med; 2020 Mar; 9(2):571-578. PubMed ID: 31865744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.